Phase II trial to study the tolerability and the effectiveness of imatinib in patients with chronic myelogenous leukemia in chronic phase in relapse after allogeneic stem cell transplantation
Phase of Trial: Phase II
Latest Information Update: 28 Aug 2012
At a glance
- Drugs Imatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Adverse reactions; Therapeutic Use
- 26 Nov 2005 New trial record.